Search

Professional Education
Alzheimer's 8: Dementia Update for PCPs: Disease-Modifying Medications Risks and Benefits
A panel of dementia specialists provide up-to-date information on new disease-modifying medications receiving FDA approval, but with specific candidate criteria. Practitioners will learn how these medications work, which of their patients may benefit, how to identify and address risks, and how to effectively communicate with patients and family members. [1.50 AMA PRA Category 1 Credits™, 1.50 Contact Hours (ANCC)]

Brad O'Brien
Brad O’Brien, president of The Doctors Insurance Agency, has worked in the medical malpractice field since 1988. He is located in Novato, California.

Stay in the Know

Sign up for The Doctor’s Practice.

Our e-newsletter features timely articles, videos, and guides on a range of patient safety topics.

Subscribe